Physician profile
Thomas Buford
NPI 1104357862
$10,839.19
in general payments reported to CMS, 2019-2025
18 companies · $3,216 in 2025
The $3,216 reported for 2025 was more than what 89% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,067 · 2022: $2,141 · 2023: $813 · 2024: $2,602 · 2025: $3,216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,437 · Travel and Lodging: $2,195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,436.77 |
| Travel and Lodging | $2,194.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $3,013.97 | 2022-2025 | Ha Minuteman G3-R, Patriot Si |
| Boston Scientific Corporation | $2,089.41 | 2021-2025 | Intracept, General - Pain Management, Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $1,864.79 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Inceptiv |
| Abbott Laboratories | $1,475.08 | 2024-2025 | Eterna, Proclaim, Prodigy |
| Curonix LLC | $267.42 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Foundation Fusion Solutions, LLC | $186.89 | 2023 | |
| Relievant Medsystems, INC. | $155.68 | 2022-2023 | Intracept |
| Si-Bone, INC. | $118.04 | 2025 | |
| Nevro Corp. | $109.95 | 2021-2024 | Senza |
| Biotronik Nro, INC. | $95.03 | 2025 | Prospera |
| Vertos Medical, INC. | $68.17 | 2023-2024 | Mild Device Kit |
| Nalu Medical, INC. | $51.10 | 2022-2025 | Nalu Neurostimulation System |
| Vertex Pharmaceuticals Incorporated | $36.23 | 2024-2025 | |
| Stryker Corporation | $34.34 | 2025 | Mild Device Kit |
| Merck Sharp & Dohme LLC | $29.16 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $19.85 | 2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $15.14 | 2022 | |
| Collegium Pharmaceutical, INC. | $14.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Buford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.